tumor

Researchers turned one tumor sample into thousands of rapid drug tests. 

With videos of dramatic cancer cell deaths and unflagging T cell attacks, Alex Ritter studies how immune cells and tumors battle with microscopic precision.

While some pediatric brain cancers have known genetic causes, many do not. Three-dimensional profiling revealed new disease mechanisms and drug targets.

The discovery of a blood vessel-promoting protein interaction found in all ovarian tumors may lead to a new druggable target for ovarian cancers.

The tumor microenvironment does more than simply support tumor growth. It may offer new avenues for cancer therapeutics.

Scientists discovered that healthy epithelial cells recognize their precancerous neighbors via the expression of proteins normally only found on immune cells. The proteins that mediate this recognition between healthy and precancerous cells provide a potential new therapeutic avenue for treating cancer.

In children, T cells effectively combat acute infections such as COVID-19, but a new study in mice suggests that the T cell response is detrimental when fighting pediatric tumors.

Sperm, bacteria, bubbles, and shuttles are just some of the latest cancer-treating microrobots in development for human use in the next few years.

Immunotherapy was a game-changer for the cancer field, but immunotherapies using cytokines like IL-2 often cause severe side effects. Researchers are developing a newly engineered blueprint to improve the therapeutic efficacy and safety of IL-2 and other cytokines.

Grant from Innovate UK to Pathios seeks to advance cancer immunotherapy